AnaptysBio, Inc. (ANAB)

46.83 -3.43 (-6.82%) USD  |  NASDAQ  |  Jan 15, 14:52
More

AnaptysBio Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Ovid Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade